Literature DB >> 21265843

Significant association of TH01 allele 9.3 and SIDS.

Cornelius Courts1, Burkhard Madea.   

Abstract

Sudden infant death syndrome (SIDS) constitutes a considerable percentage of infant death of unknown etiology. Individual catecholamine response variation is suspected to play a role in SIDS. TH01 is a tetrameric short tandem repeat marker in the tyrosine hydroxylase gene, which regulates gene expression and catecholamine production with allele 9.3 exerting a particularly strong effect on noradrenaline production. We investigated in an age-controlled study the TH01 allele frequencies in 127 cases of SIDS and 406 control cases to assess whether in SIDS cases a distinct TH01 allele distribution could be determined as has been reported by a previous study. We found that genotypes containing one or two 9.3 alleles were significantly more frequent in SIDS patients (58.2%) than in control subjects (48.4%, p=0.038), whereas all other alleles were more frequent in the control subjects. Our findings support the notion that there exists a significant association between TH01 gene configuration and SIDS.
© 2011 American Academy of Forensic Sciences.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21265843     DOI: 10.1111/j.1556-4029.2010.01670.x

Source DB:  PubMed          Journal:  J Forensic Sci        ISSN: 0022-1198            Impact factor:   1.832


  3 in total

1.  Sodium/proton exchanger 3 (NHE3) and sudden infant death syndrome (SIDS).

Authors:  Jacqueline Studer; Christine Bartsch; Cordula Haas
Journal:  Int J Legal Med       Date:  2014-03-04       Impact factor: 2.686

2.  Thermal Effects on DNA Degradation in Blood and Seminal Stains: Forensic View.

Authors:  Randa H Abdel Hady; Hayam Z Thabet; Noha Esmael Ebrahem; Heba A Yassa
Journal:  Acad Forensic Pathol       Date:  2021-03-19

3.  Assigning cause for sudden unexpected infant death.

Authors:  Carl E Hunt; Robert A Darnall; Betty L McEntire; Bruce A Hyma
Journal:  Forensic Sci Med Pathol       Date:  2015-01-30       Impact factor: 2.007

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.